Shirai Norimitsu | Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
スポンサーリンク
概要
- SHIRAI Norimitsuの詳細を見る
- 同名の論文著者
- Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.の論文著者
関連著者
-
Shirai Norimitsu
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
SHIRAI Norimitsu
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Sakimura Masanori
worldwide safety sciences
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Kurata Masaaki
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Fukushima Tamio
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Sasayama Yukiko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
今井 敏夫
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
IIDAKA Takeshi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SHIRAI Norimitsu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Iidaka Takeshi
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Tatematsu Masae
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Tatematsu M
愛知県がんセンター研究所 腫瘍病理学部
-
Sakimura Masanori
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Tsukamoto Tetsuya
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Horii Ikuo
Worldwide Safety Sciences Nagoya Laboratories Pfizer Global Research And Development Pfizer Japan In
-
高岡 雅哉
Medicinal Safety Research Laboratories Daiichi-sankyo Co. Ltd.
-
Tatematsu Masae
愛知県がんセンター研究所 腫瘍病理学部
-
Taniyama T
Okayama Univ. Okayama
-
Imai Toshio
Laboratory Of Pathology Aichi Cancer Center Research Institute
-
Tajika Masahiro
Department Of Gastroenterology Aichi Cancer Center Hospital
-
YAMASAKI Naoko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
SASAYAMA Yukiko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Takaoka Masaya
Medicinal Safety Research Laboratories Daiichi-sankyo Co. Ltd.
-
TSUJIMURA Yumiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KURATA Masaaki
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
IIDAKA Takeshi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
TAKAHASHI Mamoru
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIMOYA Machiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KATO Mariko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
FURUTA Chikako
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIRAI Norimitsu
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SATO Yasushi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
Makino Toshihiko
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.:department Of Veterinary Pathology Gr
-
Shirai Norimitsu
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Tsukamoto Takahisa
First Department Of Oral And Maxillofacial Surgery School Of Dentistry
-
Mizoshita Tsutomu
Department Of Gastroenterology And Metabolism Nagoya City University Graduate School Of Medical Scie
-
Yamasaki Naoko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Furuta Chikako
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Tsukamoto Takahisa
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Horii Ikuo
Worldwide Safety Sciences
-
Taniyama Tetsuhide
First Department Of Oral And Maxillofacial Surgery School Of Dentistry
-
Shimoya Machiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Tsukamoto T
Department Of Public Health Osaka City University Graduate School Of Medicine
-
Tsujimura Yumiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Kato Mariko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Takahashi Mamoru
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Sato Yasushi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Makita Takashi
Dept. Vet. Anat. Yamaguchi Univ.
-
Makita Takashi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.:department Of Veterinary Pathology Gr
-
Imai T
Human Genome Ctr.
-
Sasayama Yukiko
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
TOGE TETSUYA
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SHIRAI Norimitsu
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
IIDAKA Takeshi
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
著作論文
- P6-38 Relationship between hepatic enzyme induction and carcinogenicity in the p53 deficient mice treated with aminophenylnorharman(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Markers for detecting myocardial damage in rats : From a view of clinical pathology(Blood, Biomarker, Proceedings of the 32nd Annual Meeting)
- P-61 Comparison of general toxicological parameters between Crj : CD (SD) IGS and Slc : SD rats(Proceedings of the 27th Annual Meeting)
- Correlation among Clinicopathological Parameters of Myocardial Damage in Rats Treated with Isoproterenol